Business Context and Reporting Period
This Form 8-K reports on the results of MaxCyte, Inc.'s 2021 Annual Meeting of Stockholders held on October 29, 2021. The company is an emerging growth company incorporated in Delaware, with its principal executive offices in Gaithersburg, Maryland.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and voting outcomes.
Material Changes and Voting Results
Of the 100,410,560 shares outstanding, 64,754,974 shares (64.5%) were present or represented by proxy. The results for the four proposals were as follows:
- Proposal 1 (Election of Directors): All three nominees (Will Brooke, John Johnston, and Richard Douglas) were elected.
- Proposal 2 (2021 Equity Incentive Plan): Failed. Votes Against (37,190,511) exceeded Votes For (25,411,382).
- Proposal 3 (2021 Employee Stock Purchase Plan): Approved. Votes For (51,840,812) significantly exceeded Votes Against (11,754,237).
- Proposal 4 (Ratification of Auditor): Approved. CohnReznick LLP was ratified with 64,672,297 votes For versus 70,485 votes Against.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, management commentary on future outlook, specific risks, or contingencies. The document serves solely to disclose the voting results of the annual meeting.
Important Facts for Investors to Verify
- Verify the company's response and next steps regarding the rejection of the 2021 Equity Incentive Plan (Proposal 2).
- Confirm the composition of the Board of Directors following the election of the three nominees.
- Review the definitive proxy statement filed on October 1, 2021, for detailed rationale behind the voting proposals.